Danaher Corporation vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
7.7
Bullish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
DHR
Clean balance sheet with low leverage (0.4× debt-to-equity).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
BUY
Target $250.14 (+42.8%)
22 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
DHR
PFE
33.9×
Trailing P/E
19.4×
19.3×
Forward P/E
9.4×
14.9%
Profit Margin
12.4%
59.0%
Gross Margin
75.8%
7.1%
ROE
8.9%
3.7%
Revenue Growth
-1.2%
9.8%
Earnings Growth
—
0.99
Beta
0.39
—
Price / Book
—
$124.0B
Market Cap
$149.8B
$175 – $243
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →